We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Plasma HSP90α Levels Used for Detection of Hepatocellular Carcinoma

By LabMedica International staff writers
Posted on 14 Jan 2020
Print article
Image: The Roche cobas electro-chemiluminescence immunoassay kit for alpha-fetoprotein (AFP) (Photo courtesy of Toliopoulos Diagnostics).
Image: The Roche cobas electro-chemiluminescence immunoassay kit for alpha-fetoprotein (AFP) (Photo courtesy of Toliopoulos Diagnostics).
Liver cancer is composed mostly of primary liver cancers and secondary liver cancers. Hepatocellular carcinoma (HCC), as the major type of primary liver cancer, is the fifth most common tumor worldwide and the third leading cause of cancer mortality, responsible for 745,500 cancer deaths annually.

HCC screening is based on measurement of serum alpha-fetoprotein (AFP) as well as imaging technologies and histology. Heat shock protein 90 (HSP90) is an evolutionarily highly conserved intracellular molecular chaperone that is usually induced in response to cellular stress and therefore HSP90 is a potential biomarker for tumor diagnosis and prognosis.

Scientists at the Guangxi Medical University (Nanning, China) enrolled from January 1, 2018 to February 28, 2019, a total of 801 liver disease patients in the Hepatobiliary Surgery Department of the Affiliated Tumor Hospital of Guangxi Medical University. The subjects included were 659 HCC patients, 114 secondary hepatic carcinoma (SHC) patients and 28 patients with hepatic hemangioma (HH).

The levels of plasma HSP90α were measured by using the enzyme-linked immunosorbent assay (ELISA) kit for HSP90α protein (Yantai Protgen Biotechnology Development Co. Ltd, Yantai, China). The optical density was measured by using a spectrophotometer at 450 nm for the detection wavelength with 620 nm as the reference wavelength. The levels of serum AFP were measured using Cobas electro-chemiluminescence immunoassay kits (Roche Diagnostics, Mannheim, Germany).

The medical team reported that the levels of plasma HSP90α in HCC patients were significantly higher (144.08 ± 4.98 ng/mL) than in healthy donors (46.81 ± 1.11 ng/mL) and in patients with hepatic hemangioma (61.56 ± 8.20 ng/mL) or SHC (111.96 ± 10.08 ng/mL). The levels were associated with age, Barcelona Clinical Liver Cancer (BCLC) stage, levels of AFP, tumor size, tumor number, portal vein tumor thrombus (PVTT), extrahepatic metastasis (EHM), and Child-Pugh stage in the HCC cohort. In addition, the levels of plasma HSP90α showed an upward trend along with the progression of the BCLC stage. The combination of HSP90α and AFP significantly improved the diagnostic efficiency for HCC patients.

The authors concluded that the levels of plasma HSP90α in healthy donors, benign liver tumor cohort, SHC cohort and HCC cohort showed a statistically significant increasing trend in this study. The combination of HSP90α and AFP significantly improved the diagnostic efficiency for HCC patients and these simple tests can be useful in both rural and cosmopolitan settings. The study was published on January 2, 2020 in the journal BMC Cancer.

Related Links:
Guangxi Medical University
Yantai Protgen Biotechnology Development Co. Ltd
Roche Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.